The Medsi group sold 25% of Boniq’s premium checks, Vdomosti reports. The company pointed out the deterioration of investments due to the loss of service. At the same time, participants in the medical technology market talk about the growing demand for these services.
Author:
https://rb.ru/author/kossakovskaya-astasiya/
Subscribe to RB.ru on Telegram
According to the Unified State Registry of Legal Entities, the owner of Medsi’s participation in Bayonik-Madsi LLC was replaced on February 10, the amount of the transaction amounted to 37 million rubles. Fedor Viktorov was the new owner. The newspaper could not contact the background, the Medsi refused to comment.
Bioniq based on the results of blood analysis provides personal recommendations for nutrition, taking vitamins and minerals. The service can also independently produce the recommended vitamins complexes to customers in Switzerland. The maximum offer (130 thousand rubles) includes checking, the medical’s final consultation, the recommendation of the vitamin complex and its annual supply.
Negative growth. In 2020, Medsi invested 500 million rubles in Bioniq in exchange for an advance payment for the provision of customers of the clinical network for seven years. From the “Medsi” report it follows that the group discovered signs of deterioration of investments, since the service “incurs losses and is in the development stage.” Bioniq has not been profitable since the Foundation: in 2023, the company increased a loss of 68%, to 118.2 million rubles, Vdomosti Write.
Boom of vitamins. Participants of the Medical Services Market indicate the increase in demand for analysis with personal purpose of vitamins. In 2024, fat -soluble vitamins analysis were carried out by 51% more than in 2023, the increase in the number of studies for vitamin D amounted to 97% year before the year, said the director of Laboratory Medicine and the Production of Labksvest and Q-Clinic Love Stankevich.
The founder of Reztom, Alexei Remez, confirmed this trend. “The issue is quite hot, the demand for customization in medicine, online consultations and well -being is growing. The custom vitamin segment is growing by 10-15% per year, “said Reme, adding that one of the causes of the loss of loss of Bioniq could be high competition and the” skepticism of the audience. “
Author:
Anastasia Kossakovskaya
Source: RB
I am a professional journalist and content creator with extensive experience writing for news websites. I currently work as an author at Gadget Onus, where I specialize in covering hot news topics. My written pieces have been published on some of the biggest media outlets around the world, including The Guardian and BBC News.
